PDS Biotechnology
PDSB
PDSB
60 hedge funds and large institutions have $12.2M invested in PDS Biotechnology in 2018 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
91% less capital invested
Capital invested by funds: $141M → $12.2M (-$129M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $9K
Holders
60
Holding in Top 10
–
Calls
–
Puts
$9K
Top Buyers
| 1 | +$420K | |
| 2 | +$337K | |
| 3 | +$273K | |
| 4 |
AG
Algert Global
San Francisco,
California
|
+$132K |
| 5 |
ECM
Element Capital Management
New York
|
+$130K |
Top Sellers
| 1 | -$29.9M | |
| 2 | -$19.4M | |
| 3 | -$9.14M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$8.84M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$8.27M |